Edgewise Therapeutics, Inc. financial data

Symbol
EWTX on Nasdaq
Industry
Pharmaceutical Preparations
Location
1715 38 Th St, Boulder, Colorado
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 9, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 2.39K % -5.8%
Debt-to-equity 5.51 % +9.12%
Return On Equity -29.1 % -23.1%
Return On Assets -27.6 % -22.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 93.4M shares +47.6%
Common Stock, Shares, Outstanding 93.3M shares +47.4%
Entity Public Float 386M USD +55.7%
Common Stock, Value, Issued 9K USD +50%
Weighted Average Number of Shares Outstanding, Basic 87.6M shares +38.4%
Weighted Average Number of Shares Outstanding, Diluted 87.6M shares +38.4%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 98.7M USD +57.2%
General and Administrative Expense 24.7M USD +25%
Operating Income (Loss) -123M USD -49.5%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -106M USD -39.6%
Earnings Per Share, Basic -1.54 USD/shares -16.7%
Earnings Per Share, Diluted -1.54 USD/shares -16.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 30.3M USD -37.3%
Assets, Current 541M USD +62.4%
Property, Plant and Equipment, Net 10.2M USD -2.04%
Operating Lease, Right-of-Use Asset 2.2M USD -8.16%
Other Assets, Noncurrent 348K USD +38.6%
Assets 554M USD +59.9%
Accounts Payable, Current 4.72M USD +21.9%
Employee-related Liabilities, Current 2.92M USD +41%
Accrued Liabilities, Current 5.97M USD 0%
Liabilities, Current 14.6M USD +14.8%
Operating Lease, Liability, Noncurrent 4.27M USD -12%
Other Liabilities, Noncurrent 192K USD
Liabilities 18.9M USD +7.43%
Accumulated Other Comprehensive Income (Loss), Net of Tax -861K USD -243%
Retained Earnings (Accumulated Deficit) -273M USD -63.2%
Stockholders' Equity Attributable to Parent 535M USD +62.7%
Liabilities and Equity 554M USD +59.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -28.6M USD -25.3%
Net Cash Provided by (Used in) Financing Activities 241M USD +1147867%
Net Cash Provided by (Used in) Investing Activities -268M USD -647%
Common Stock, Shares Authorized 1B shares 0%
Common Stock, Shares, Issued 93.3M shares +47.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -55.8M USD -313%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 30.3M USD -37.3%
Deferred Tax Assets, Valuation Allowance 69.6M USD +74.2%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 69.6M USD +74.2%
Operating Lease, Liability 2.2M USD
Depreciation 1.83M USD +281%
Payments to Acquire Property, Plant, and Equipment 297K USD -93.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -106M USD -43.6%
Lessee, Operating Lease, Liability, to be Paid 3.3M USD
Property, Plant and Equipment, Gross 13.3M USD +13.9%
Operating Lease, Liability, Current 984K USD +23.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 328K USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 777K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 446K USD
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 200M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 457K USD
Additional Paid in Capital 809M USD +62.9%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 18.6M USD +45.5%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%